IRD vs PODD · rev $11.0M vs P/E 34, rev $2.07B
Opus Genetics, Inc. (IRD) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
IRD currently screens at market cap $35.7M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the IRD and PODD stock pages for the full models.
Not investment advice.